Oak Ridge Investments LLC Blueprint Medicines Corp Transaction History

Oak Ridge Investments LLC

$1.25 Billion
Q4 2024

A detailed history of Oak Ridge Investments LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Oak Ridge Investments LLC holds 14,197 shares of BPMC stock, worth $1.59 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

14,197

Previous 15,135 6.2%

Holding current value

$1.59 Million

Previous $1.4 Million 11.51%

% of portfolio

0.1%

Previous 0.12%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$82.48 - $101.39 $77,366 - $95,103	-938 Reduced 6.2%	14,197 $1.24 Million
Q3 2024 Oct 28, 2024	SELL	$84.1 - $120.5 $51,216 - $73,384	-609 Reduced 3.87%	15,135 $1.4 Million
Q2 2024 Jul 16, 2024	BUY	$85.18 - $108.78 $302,814 - $386,712	3,555 Added 29.17%	15,744 $1.7 Million
Q1 2024 May 01, 2024	BUY	$73.17 - $99.79 $5,268 - $7,184	72 Added 0.59%	12,189 $1.16 Million
Q4 2023 Jan 16, 2024	SELL	$43.96 - $92.84 $75,127 - $158,663	-1,709 Reduced 12.36%	12,117 $1.12 Million
Q3 2023 Oct 30, 2023	SELL	$46.9 - $66.0 $20,964 - $29,502	-447 Reduced 3.13%	13,826 $694,000
Q2 2023 Aug 07, 2023	SELL	$42.2 - $66.37 $20,678 - $32,521	-490 Reduced 3.32%	14,273 $902,000
Q1 2023 Apr 14, 2023	SELL	$37.97 - $50.0 $16,782 - $22,100	-442 Reduced 2.91%	14,763 $664,000
Q4 2022 Jan 24, 2023	SELL	$41.06 - $66.48 $35,393 - $57,305	-862 Reduced 5.37%	15,205 $0
Q3 2022 Nov 08, 2022	BUY	$49.93 - $77.7 $9,636 - $14,996	193 Added 1.22%	16,067 $1.06 Million
Q2 2022 Jul 28, 2022	SELL	$45.23 - $70.15 $56,537 - $87,687	-1,250 Reduced 7.3%	15,874 $802,000
Q1 2022 Apr 22, 2022	SELL	$54.1 - $110.08 $529,098 - $1.08 Million	-9,780 Reduced 36.35%	17,124 $1.09 Million
Q4 2021 Feb 01, 2022	SELL	$94.25 - $115.99 $41,941 - $51,615	-445 Reduced 1.63%	26,904 $2.88 Million
Q3 2021 Nov 05, 2021	SELL	$80.98 - $109.47 $50,855 - $68,747	-628 Reduced 2.24%	27,349 $2.81 Million
Q2 2021 Jul 30, 2021	SELL	$82.78 - $101.0 $150,245 - $183,315	-1,815 Reduced 6.09%	27,977 $2.46 Million
Q1 2021 May 12, 2021	SELL	$90.71 - $108.28 $19.5 Million - $23.3 Million	-215,254 Reduced 87.84%	29,792 $2.9 Million
Q1 2021 May 04, 2021	BUY	$90.71 - $108.28 $19.4 Million - $23.2 Million	213,862 Added 685.81%	245,046 $23.8 Million
Q4 2020 Feb 03, 2021	SELL	$92.08 - $124.48 $682,128 - $922,147	-7,408 Reduced 19.2%	31,184 $3.5 Million
Q3 2020 Nov 12, 2020	SELL	$66.45 - $92.7 $194,233 - $270,962	-2,923 Reduced 7.04%	38,592 $3.58 Million
Q2 2020 Aug 05, 2020	SELL	$57.09 - $79.27 $213,459 - $296,390	-3,739 Reduced 8.26%	41,515 $3.24 Million
Q1 2020 May 13, 2020	SELL	$48.11 - $82.22 $98,192 - $167,811	-2,041 Reduced 4.32%	45,254 $2.65 Million
Q4 2019 Feb 05, 2020	SELL	$66.73 - $82.59 $591,161 - $731,664	-8,859 Reduced 15.78%	47,295 $3.79 Million
Q3 2019 Nov 07, 2019	BUY	$72.9 - $101.41 $1.53 Million - $2.13 Million	21,020 Added 59.83%	56,154 $4.13 Million
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $2.58 Million - $3.44 Million	35,134 New	35,134 $3.32 Million

Others Institutions Holding BPMC

# of Institutions

350

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $6.69B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.

Account

Oak Ridge Investments LLC Blueprint Medicines Corp Transaction History